Warren Lucinda
SEC insider (Form 3/4/5 filer). CIK 0002035620. CHIEF BUSINESS OFFICER at Cue Biopharma, Inc. (CUE). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2026. Located in BOSTON, MA.
Companies Warren Lucinda has filed insider reports for
- Cue Biopharma, Inc. (CUE): Officer, CHIEF BUSINESS OFFICER
Warren Lucinda
CIK: 0002035620
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cue Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 9, 2026CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
250K shares- - Sep 29, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
125K shares- - Mar 21, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
250K shares- - Sep 3, 2024CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
350K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 9, 2026 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 250,000 | - | - | Direct |
| Sep 29, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 125,000 | - | - | Direct |
| Mar 21, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 250,000 | - | - | Direct |
| Sep 3, 2024 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 350,000 | - | - | Direct |
1-4 of 4 transactions